HALOZYME THERAPEUTICS, INC. ($HALO)
Filing Information
| Accession Number | 0001159036-26-000070 |
|---|---|
| Form Type | 4 |
| Filing Date | May 13, 2026 |
| Document | View SEC Filing |
Transactions
18
Total Shares
150,000
Total Value
$4,640,874.74
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 11, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | May 11, 2026 | Sale | 9,725 | $64.63 | $628,536.47 | 778,055 | Direct | โ | View Details | |
Director | Common Stock | โ | May 11, 2026 | Sale | 3,575 | $65.46 | $234,012.35 | 774,480 | Direct | โ | View Details | |
Director | Common Stock | โ | May 11, 2026 | Sale | 6,700 | $66.33 | $444,390.90 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 787,780 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 100 | $67.85 | $6,785.00 | 787,680 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 1,398 | $70.29 | $98,261.23 | 786,282 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 9,802 | $71.37 | $699,568.74 | 776,480 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 5,900 | $72.15 | $425,673.20 | 770,580 | Direct | โ | View Details | |
Director | Common Stock | โ | May 12, 2026 | Sale | 2,800 | $73.12 | $204,738.80 | 767,780 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 777,780 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Sale | 2,100 | $68.10 | $143,014.20 | 775,680 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Sale | 3,350 | $68.88 | $230,748.00 | 772,330 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Sale | 3,950 | $69.79 | $275,658.65 | 768,380 | Direct | โ | View Details | |
Director | Common Stock | โ | May 13, 2026 | Sale | 600 | $70.81 | $42,487.20 | 767,780 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | May 11, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 81,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | May 12, 2026 | Exercise/Conversion | 20,000 | $12.07 | $241,400.00 | 61,923 | Direct | โ | View Details | |
Director | Option to Purchase Common Stock | Derivative | May 13, 2026 | Exercise/Conversion | 10,000 | $12.07 | $120,700.00 | 51,923 | Direct | โ | View Details |